NAMI vs YXT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 18, 2026

NAMI

37.8
AI Score
VS
NAMI Wins

YXT

37.7
AI Score

Investment Advisor Scores

NAMI

38score
Recommendation
SELL

YXT

38score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NAMI YXT Winner
Revenue 59.06M 48.65M NAMI
Net Income -13.49M -22.73M NAMI
Net Margin -22.8% -46.7% NAMI
Operating Income -14.91M -20.17M NAMI
ROE -112.5% -212.9% NAMI
ROA -49.1% -31.3% YXT
Total Assets 27.49M 72.51M YXT
Cash 9.19M 16.44M YXT
Current Ratio 1.53 0.49 NAMI
Free Cash Flow -3.63M -21.08M NAMI

Relative Price Performance (Last 90 Days)

NAMI 1M: -21.0% · 3M: +562.2% YXT 1M: -2.0% · 3M: +526.9%

Current Technical Phase

NAMI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 43.0 · Price: $2.49

YXT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.3 · Price: $2.94

Fundamentals Snapshot

Metric NAMI YXT
Market Cap
Forward P/E 0.0 -4.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.1% 0.7%
Operating Margin -0.4% 0.0%
EPS -4.68 -2.41
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NAMI is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.